Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Period:
Draw Mode:
| Volume | 26,197,969 |
|
|||||
| News | - | ||||||
| Day High | 0.212 | Low High |
|||||
| Day Low | 0.1671 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Kintara Therapeutics Inc | KTRA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.0555 | 33.04% | 0.2235 | 19:59:59 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.19 | 0.1671 | 0.212 | 0.1879 | 0.168 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 18,672 | 26,197,969 | $ 0.1855112 | $ 4,860,017 | - | 0.081 - 5.60 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:59 | formt | 250 | $ 0.2235 | USD |
Kintara Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 7.42M | 39.04M | - | 0 | -15.02M | -0.38 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Kintara Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical KTRA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.16 | 0.212 | 0.15 | 0.1729733 | 10,758,933 | 0.0635 | 39.69% |
| 1 Month | 0.1618 | 0.212 | 0.125 | 0.1610216 | 8,603,121 | 0.0617 | 38.13% |
| 3 Months | 0.0987 | 0.24 | 0.081 | 0.141737 | 13,898,583 | 0.1248 | 126.44% |
| 6 Months | 0.3656 | 0.4961 | 0.081 | 0.1411032 | 11,525,554 | -0.1421 | -38.87% |
| 1 Year | 3.04 | 5.60 | 0.081 | 0.1763624 | 5,889,187 | -2.82 | -92.65% |
| 3 Years | 85.50 | 142.50 | 0.081 | 8.13 | 2,961,248 | -85.28 | -99.74% |
| 5 Years | 60.50 | 167.50 | 0.081 | 13.52 | 2,504,000 | -60.28 | -99.63% |
Kintara Therapeutics Description
| Kintara Therapeutics Inc is engaged in the development of novel cancer therapies for patients with unmet medical needs. The company is developing two late-stage, Phase 3-ready therapeutics for clear unmet medical needs with reduced risk development programs. The two programs are VAL-083 for GBM and REM-001 for CMBC. VAL-083 is a small-molecule chemotherapeutic with a novel mechanism of action that has demonstrated clinical activity against a range of cancers, including the central nervous system, ovarian, and other solid tumors. The company is also advancing its proprietary late stage photodynamic therapy (PDT) platform that holds promise as a localized cutaneous or visceral tumor treatment as well as in other potential indications. |
